BGV
Venture capitalActively deployingSilicon Valley · Seed–Late Stage · 10 people tracked
Also known as BGV Investments
Find your way into BGV
2,233 people in our graph share verified history with the BGV team — schools, employers, funds. One of them is your warm intro.
Investment thesis
BGV is a cross-border VC platform rooted in Silicon Valley that backs enterprise-focused B2B technology companies, deploying capital from seed stage to IPO. The firm concentrates on what it calls Enterprise 5.0 companies and cross-border innovation, targeting startups driving leapfrog shifts in enterprise automation and productivity by combining intelligent machines with human ingenuity while emphasizing responsible, human-centric design. Founded by immigrant entrepreneurs-turned-investors, BGV positions itself to provide not only financing but also operational expertise, global resources, and cross-border advisory support to help founders build global B2B technology companies.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from public directories
What they invest in
from 24 of 30 portfolio companiesAI & Machine Learning ×15SaaS ×13Enterprise Software ×11Biotech ×8Healthtech ×8Data & Infrastructure ×4Developer Tools ×4Deep Tech ×3
HQs:United States×16Germany×1United Kingdom×1Netherlands×1
Investments · 30 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 42023 · 22022 · 32021 · 22020 · 42019 · 12016 · 118 dated
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.
AI & Machine LearningBiotechHealthtech
Megan McGill(Chief Executive Officer)inIain Dukes(Chief Business Officer / Chairman of the Board)inNikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)in
Co-investorsNew Enterprise Associates (NEA)OrbiMedTorrey Pines Investment
Dunad Therapeutics is a biotech company developing oral small-molecule medicines using a covalent chemistry discovery platform to target neurodegenerative diseases such as ALS, Parkinson's disease, and FTD.
BiotechDeep TechCambridge, GB
Pearl Huang(President & CEO)inStephen Huhn(CMO)
Co-investorsAlpha Wave GlobalEpidarex Capital
Lyzr builds infrastructure and platforms for deploying production-grade AI agents in enterprises, with emphasis on governance, security, observability, and human oversight.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSJersey City, US
Siva Surendira(Founder & CEO)inSurendirasiva Selvaraj(Executive Officer, Director)Jithin George(Founder)in
BoardMadhu Shalini Iyer(Director)inHenry Ford III(Director)
Co-investorsRocketship.vcAccenture VenturesArka Venture LabsBetter CapitalGFT VenturesIn-Q-Tel+2 more
NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH.
BiotechDigital HealthHealthtech
Co-investorsNew Science VenturesvenBio PartnersYsios CapitalNovo HoldingsBioGeneration VenturesForbion+1 more
Terret provides a platform for managing revenue operations, designed for sales and go-to-market teams at startups and enterprises.
AI & Machine LearningEnterprise SoftwareSaaSSales Tech
Justin Shriber(Cofounder and CEO)Amit Sasturkar(Cofounder and CTO)
Co-investorsEMERGENT VENTURESNGP Capital
Gamut is an open-source, self-hostable platform where people and AI agents collaborate in shared threads, with agents that use a real browser, connect to APIs and MCP servers, run on schedules or webhooks, and operate from tools like Slack, Telegram, and iMessage.
AI & Machine LearningFuture of WorkSaaSBerkeley, US
Iddo Gino(Executive Officer, Director, Promoter)Sigal Shaked(Executive Officer, Director)
Board seatEric Buatois· per SEC Form D
Co-investorsBenhamou Global VenturesHuman Capital
AI & Machine LearningEnterprise SoftwareMarketing TechSaaSSales TechMountain View, US
Paul Cothenet(Founder)inAnselme Le Van(Founder)
Board seatEric Buatois· per SEC Form D · $6M raise · filed Jan 2020
Co-investorsMatchstick VenturesTechstarsBenhamou Global VenturesFelicis Ventures
.png)
Onymos offers DocKnow, a document and data processing platform for clinical laboratories that captures, validates, and enriches intake documents such as test requisition forms and medical records.
AI & Machine LearningCloud ComputingDeveloper ToolsHealthtechSaaSRedwood Shores, US
SHIVAGURU NATHAN(Executive Officer, Director)Shiva Nathan(Founder & CEO)inShiva N(Founder)Bhavani Vangala(CTO)in
Board seatEric Buatois· per SEC Form D · $2.2M raise · filed Feb 2020
Co-investorsGreatPoint VenturesBenhamou Global VenturesEngineering CapitalIndustry Ventures
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedAndera PartnersForbionFountain Healthcare PartnersHTGFPMV+2 more
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsBioGeneration VenturesThuja CapitalSeroba Life Sciences
Cybersecurity for critical infrastructure, ICS and OT (acquired by OPSWAT)
Bethesda, US
Francis Cianfrocca(Director)Bob Lam(Executive Officer)Michael Dager(Executive Officer, Director)
BoardAlberto Yepez(Director)Christopher T Winkler(Director)Anik Bose(Director)in
Co-investorsEvolution Equity PartnersForgePoint CapitalBenhamou Global Ventures
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsCambridge Innovation CapitalHadean VenturesSeroba Life SciencesBioGeneration VenturesForbionGimv+2 more
Constella provides identity theft monitoring that continuously scans the surface, deep, and dark web for exposed corporate and personal credentials, infostealer logs, and leaked session cookies.
AI & Machine LearningCybersecurityData & InfrastructureEnterprise SoftwareSaaS
Co-investorsC5 CapitalTheVentureCityAdara VenturesForgePoint Capital
No factual description available; likely a sector classification label rather than a real startup.
Co-investorsPresidio VenturesSozo Ventures
EverestLabs builds RecycleOS, an AI-powered operating system for recycling plants that uses computer vision, AI, and robotics to identify and sort recyclable materials in Material Recovery Facilities (MRFs).
AI & Machine LearningCircular EconomyClimate TechImpact & Social GoodRoboticsFremont, US
JD Ambati(Founder/Chief Strategy Officer)inR Paul Singh(CEO)
Co-investorsSierra VenturesTransLink CapitalUnanimous CapitalXplorer CapitalBenhamou Global VenturesHike Ventures+1 more
Evinced offers an AI-powered chatbot focused on digital accessibility that answers developer and team questions, reviews code for accessibility issues across web and mobile frameworks, and can read design screenshots.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSPalo Alto, US
Navin R. Thadani(Founder)inGal Moav(Founder)in
Co-investorsBenhamou Global VenturesCapital One VenturesEngineering CapitalInsight PartnersM12 (Microsoft's Venture Fund)SoftBank Vision Fund
Fiddler AI provides an AI observability and control platform offering experiments, monitoring, guardrails, and governance for enterprise AI agents and compound AI systems.
AI & Machine LearningData & InfrastructureEnterprise SoftwarePalo Alto, US
Krishna Gade(Founder & CEO)in
Co-investorsAngel Collective Opportunity FundaVentureBenhamou Global VenturesCisco InvestmentsDallas Venture CapitalDentsu Ventures+20 more
i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.
BiotechDeep TechHealthtechSan Diego, US
Co-investorsTorrey Pines InvestmentBioGeneration VenturesOrbiMed
Macrometa builds a globally distributed cloud platform designed for real-time applications that require high performance and low latency.
AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsE-commerceEnterprise SoftwareRetail TechSaaS
Co-investorsAurum Venture PartnersVU Venture PartnersBenhamou Global VenturesDnx VenturesPartech VenturesPelion Venture Partners+2 more
Enterprise Software
Co-investorsBonfire VenturesCommerce VenturesConexus Venture CapitalCRV (Charles River Ventures)Emery CapitalFinTech Ventures+2 more
Pyze provides an Execution Intelligence platform that captures how employees actually work inside web-based enterprise applications, helping organizations measure workforce productivity, find automation opportunities, and evaluate AI agent deployments.
AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaS
Co-investorsAAF Management Ltd.Candou VenturesCorrelation VenturesBenhamou Global VenturesDoubleRockIlluminate Ventures
River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies.
BiotechHealthtechMedical Devices
Robert Passier(Founder)in
Co-investorsKIKK CapitalBioGeneration VenturesOost NL
E-commerceLogistics & Supply ChainRetail TechSaaSEl Segundo, US
Nicolas Stehle(Executive Officer, Director)inOlivier Schott(Director)inPhilippe Bouissou(Director)
BoardEric Buatois(Director)in
Co-investorsAdara VenturesBenhamou Global VenturesFrench Partners
Totango offers a customer success platform for businesses to manage customer relationships and drive revenue retention and growth, including AI-powered features like account summaries and a customer intelligence engine.
AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Mateo, US
Guy Nirpaz(Founder)inTomer Manor(VP Finance)inKeith Frankel(CEO)inSherman Chu(Director)inTomas Carlos Tovar(Director)Nechemia Jacob Peres(Director)
Co-investorsGreat Hill PartnersBenhamou Global VenturesCanvas VenturesGarage CapitalBioGeneration VenturesGemini Israel Ventures+1 more
VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.
BiotechHealthtechMedical Devices
Pieter ReitsmainJohn Glasspool(Chief Executive Officer)in
Co-investorsSound BioventuresYsios CapitalBioGeneration VenturesEICEQT Life SciencesInkef+2 more
Zelros (now part of Earnix) offers an AI decisioning and orchestration system built for insurers, covering pricing, underwriting, and customer engagement across multiple lines of business.
AI & Machine LearningInsurTechSaaS
Co-investors42CAPIsaiISAI GestionBenhamou Global Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
3 acquisitionsMadKuduacq. by HG InsightsBayshore Networksacq. by OPSWATScalefastacq. by ESW
Portfolio news
latest coverage across their companies
named · lonelyentrepreneur.com · Aug 14, 2026
Evinced · trysignalbase.com · Jul 14, 2026
Lyzr · citybiz.co · Jul 13, 2026
Fiddler AI · thesaasnews.com · Jan 30, 2026
Fiddler Labs, Inc. · fiddler.ai · Jan 27, 2026
Datawizz · pulse2.com · Oct 5, 2025
Frequently asked questions
- How many investments has BGV made?
- BGV has 30 tracked investments, 3 of which have exited, including 5 dated in the last 24 months.
- What stage does BGV invest at?
- BGV invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does BGV focus on?
- BGV focuses on AI & Machine Learning, Data & Infrastructure, Enterprise Software, Robotics, SaaS, Semiconductors.
- Where is BGV located?
- BGV is headquartered in Silicon Valley, US.
Media · Podcasts & interviews
featuring the teamInterview with BlockStars: Yashwanth Hemaraj, BGV General Partner
Benhamou Global Ventures · Yashwanth Hemaraj
VC Strategy, with Yashwanth Hemaraj Partner at BGV | Episode #4
The Blueprint Podcast · Yashwanth Hemaraj
Keynote - Eric Benhamou (Founder, BGV) | Arka Spring Showcase '21
Arka Venture Labs · Eric Benhamou
They are Innovation - Eric BENHAMOU - Founder & Managing Director BGV | Videos & Películas en Vimeo
BLUMORPHO · Eric Benhamou · vimeo.com
IFG Network Testimonial- Anik Bose BGV - Benhamou Global Ventures on Vimeo
marcus evans summit marketing · Anik Bose · vimeo.com
IFG Network Testimonial: Anik Bose, BGV - Benhamou Global Ventures | Videos & Movies on Vimeo
IFG Network · Anik Bose · vimeo.com
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
Visionaries Club is a European venture capital firm backing early-stage B2B and AI-driven technology companies, connecting top founders with a network of leading tech operators and industrial family entrepreneurs who serve as LPs, mentors and customers.